During the last decade remarkable progress has been made in our unders
tanding of the malignant phenotype. There is evidence that a series of
genetic changes are involved in the conversion of a normal cell to a
malignant one. These changes have been directly identified with mutati
ons in various genes usually involved in cell growth and proliferation
. Two main classes of genes have been characterized: oncogenes, which
promote growth and tumor suppressor genes, which restrain growth. Whil
e oncogenes have been studied in relative detail, little is known abou
t tumor suppressor genes. However recent studies revealed that loss of
tumor suppressor genes are a common mechanism for the progression of
cancer and are of prognostic value. In this review we focus on the rol
e of these tumor suppressor genes in urologic tumors in experimental a
s well as clinical studies.